Atlas Trials

Exploring the Role of Serum Methylmalonic Acid (MMA) in Breast Cancer

Clinical trial NCT05352737 · COMPLETED

Trial details

NCT number
NCT05352737
Sponsor
KU Leuven
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2021-01-22
Primary completion
2022-06-24
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.